Related Experiment Videos
Inhibitory autophosphorylation of multifunctional Ca2+/calmodulin-dependent protein kinase analyzed by site-directed
1Department of Pharmacology, Stanford University School of Medicine, California 94305-5322.
Abstract:
Initial autophosphorylation of multifunctional Ca2+/calmodulin-dependent protein kinase (CaM kinase) occurs at Thr286 (the "autonomy" site) and converts the kinase from a Ca(2+)-dependent to a partially Ca(2+)-independent or autonomous enzyme. After removal of Ca2+/calmodulin, the autonomous kinase undergoes a "burst" of inhibitory autophosphorylation at sites distinct from the autonomy site which may be masked in the presence of bound calmodulin. This burst of Ca(2+)-independent autophosphorylation blocks the ability of calmodulin to activate the kinase. We have used site-directed mutagenesis to replace putative inhibitory autophosphorylation sites within the calmodulin binding domain of recombinant alpha-CaM kinase with nonphosphorylatable alanines and examined the effects on autophosphorylation, kinase activity, and calmodulin binding. Although prominent Ca(2+)-independent autophosphorylation occurs within the calmodulin binding domain at Thr305, Thr306, and Ser314 in wild-type alpha-CaM kinase, the inhibitory effect on kinase activity and calmodulin binding is retained in mutants lacking any one of these three sites. However, when both Thr305 and Thr306 are converted to alanines the kinase does not display inhibition of either activity or calmodulin binding. Autophosphorylation at either Thr305 or Thr306 is therefore sufficient to block both binding and activation of the kinase by Ca2+/calmodulin. Thr306 is also slowly autophosphorylated in a basal reaction in the continuous absence of Ca2+/calmodulin. Autophosphorylation of Thr306 by the kinase in either its basal or autonomous state suggests that in the absence of bound calmodulin, the region of the autoregulatory domain surrounding Thr306, rather than the region near the autonomy site, lies nearest the peptide substrate binding site of the kinase.
Insights
Ca2+/calmodulin-dependent protein kinase (CaM kinase) autophosphorylation at Thr305 or Thr306 inhibits calmodulin binding and activation. This finding reveals key regulatory mechanisms for CaM kinase activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Ca2+/calmodulin-dependent protein kinase (CaM kinase) is a crucial enzyme regulated by autophosphorylation.
- Initial autophosphorylation at Thr286 confers Ca2+ independence, creating an autonomous state.
- Further Ca2+-independent autophosphorylation can inhibit kinase activity and calmodulin binding.
Purpose of the Study:
- To investigate the role of specific inhibitory autophosphorylation sites within the calmodulin binding domain of alpha-CaM kinase.
- To determine the impact of mutations at these sites on kinase activity, autophosphorylation, and calmodulin binding.
Main Methods:
- Site-directed mutagenesis was used to replace putative inhibitory autophosphorylation sites (Thr305, Thr306, Ser314) with alanines in recombinant alpha-CaM kinase.
- Autophosphorylation, kinase activity, and calmodulin binding were assessed in wild-type and mutant enzymes.
Main Results:
- Wild-type alpha-CaM kinase undergoes Ca2+-independent autophosphorylation at Thr305, Thr306, and Ser314, inhibiting activity and calmodulin binding.
- Mutants lacking individual sites retained inhibitory effects.
- Mutants with both Thr305 and Thr306 converted to alanines showed no inhibition of activity or calmodulin binding.
- Autophosphorylation at either Thr305 or Thr306 alone is sufficient to block calmodulin binding and activation.
Conclusions:
- Thr305 and Thr306 within the calmodulin binding domain are critical sites for inhibitory autophosphorylation in alpha-CaM kinase.
- Autophosphorylation at these sites effectively prevents calmodulin from binding and activating the enzyme.
- The findings elucidate a novel regulatory mechanism controlling CaM kinase function, particularly the role of Thr306 in the absence of calmodulin.